Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2025-12-28 @ 2:09 PM
Study NCT ID:
NCT04943068
Status:
COMPLETED
Last Update Posted:
2024-11-13
First Post:
2021-06-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)
Sponsor:
Kwang Dong Pharmaceutical co., ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-16
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-10
First Submit QC Date:
None
Study First Post Date:
2021-06-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-11
Last Update Post Date:
2024-11-13
Last Update Post Date Type:
ACTUAL